Myelin Repair Foundation-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Myelin Repair Foundation - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013264
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:17
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Myelin Repair Foundation (MRF) is a medical research organization that discovers and develops myelin repair therapeutics for multiple sclerosis. The organization publishes various peer-reviewed scientific articles, identifies different myelin repair treatment targets and discovers multiple research tools, animal models and assays, among others. MRF’s accelerated research collaboration model addresses all phases in the drug discovery field, from initial research all the way to licensing by commercial drug developers. The organization provides research in various areas such as discovery biology, translational medicine and Clinical trials, among others. MRF is headquartered in Saratoga, California, the US.

Myelin Repair Foundation – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Myelin Repair Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
Myelin Repair Foundation Enters Into Agreement With Bionure For Multiple Sclerosis 10
Myelin Repair Foundation Enters Into Agreement With Gencia To Advance Myelin Repair Therapeutics For Multiple Sclerosis 11
Myelin Repair Foundation Enters Into Co-Development Agreement With ENDECE Neural 12
Licensing Agreements 13
Biogen Idec Enters Into Licensing Agreement With Myelin Repair Foundation 13
Myelin Repair Foundation – Key Competitors 14
Myelin Repair Foundation – Key Employees 15
Myelin Repair Foundation – Locations And Subsidiaries 16
Head Office 16
Appendix 17
Methodology 17
About GlobalData 17
Contact Us 17
Disclaimer 17

List of Tables
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Key Facts 2
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Myelin Repair Foundation, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Myelin Repair Foundation, Deals By Therapy Area, 2011 to YTD 2017 8
Myelin Repair Foundation, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Myelin Repair Foundation Enters Into Agreement With Bionure For Multiple Sclerosis 10
Myelin Repair Foundation Enters Into Agreement With Gencia To Advance Myelin Repair Therapeutics For Multiple Sclerosis 11
Myelin Repair Foundation Enters Into Co-Development Agreement With ENDECE Neural 12
Biogen Idec Enters Into Licensing Agreement With Myelin Repair Foundation 13
Myelin Repair Foundation, Key Competitors 14
Myelin Repair Foundation, Key Employees 15

★海外企業調査レポート[Myelin Repair Foundation-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Sigma-Tau HealthScience USA, Inc:戦略・SWOT・企業財務分析
    Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report Summary Sigma-Tau HealthScience USA, Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, produ …
  • Kenon Holdings Ltd (KEN):企業の財務・戦略的SWOT分析
    Kenon Holdings Ltd (KEN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Hostess Brands Inc (TWNK):企業の財務・戦略的SWOT分析
    Hostess Brands Inc (TWNK) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Cancer Research UK-製薬・医療分野:企業M&A・提携分析
    Summary Cancer Research UK (CRUK) is a research institution which offers clinical research services to treat cancer. The institute offers research services for womb cancer, lung cancer, bladder cancer, bone cancer, bowel cancer, brain tumours, breast cancer, carcinoid, cervical cancer, children's ca …
  • SR Technics Holding:企業の戦略的SWOT分析
    SR Technics Holding - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Bioton SA (BIO):企業の財務・戦略的SWOT分析
    Bioton SA (BIO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The British United Provident Association Limited:企業の戦略・SWOT・財務分析
    The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report Summary The British United Provident Association Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, …
  • Silence Therapeutics Plc (SLN):企業の財務・戦略的SWOT分析
    Summary Silence Therapeutics plc (Silence Therapeutics), formerly SR Pharma plc is a developer of therapeutics that channels gene silencing to cure disease. The company develops pipeline products such as Atu027 and Atu111. Its Atu027 is developed for the treatment of pancreatic, head and neck cancer …
  • Huadian Power International Corporation Ltd (1071):電力:M&Aディール及び事業提携情報
    Summary Huadian Power International Corporation Ltd (HPICL) is an electric utility. It constructs and operates power plants, including coal- or gas-fired generating units and renewable energy projects. The company has plants at the electricity and heat load centers or regions with abundant coal reso …
  • Core-Mark Holding Company, Inc. (CORE):企業の財務・戦略的SWOT分析
    Core-Mark Holding Company, Inc. (CORE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths a …
  • Telecom Argentina S.A.
    Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report Summary Telecom Argentina S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Deutsche Lufthansa AG:企業のM&A・事業提携・投資動向
    Deutsche Lufthansa AG - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Deutsche Lufthansa AG Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M …
  • PNM Resources, Inc. (PNM)-エネルギー分野:企業M&A・提携分析
    Summary PNM Resources, Inc. (PNMR) is an investor-owned holding company that provides electricity and electric services in New Mexico and Texas. It has interests in PNM and TNMP utilities. PNM produces electricity from coal, natural gas, nuclear, solar, wind, and geothermal sources; transmits and di …
  • Achem Technology Corporation
    Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report Summary Achem Technology Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • METRO Retail Stores Group Inc (MRSGI):企業の財務・戦略的SWOT分析
    METRO Retail Stores Group Inc (MRSGI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths an …
  • Just Energy Group Inc. (JE)-エネルギー分野:企業M&A・提携分析
    Summary Just Energy Group Inc. (Just Energy) is a provider of energy management solutions. The company offers natural gas, electricity, solar energy, green energy and energy efficiency tools and products to customers. It serves consumer and commercial markets through fixed price contracts, variable- …
  • VOXX International Corporation:企業の戦略・SWOT・財務情報
    VOXX International Corporation - Strategy, SWOT and Corporate Finance Report Summary VOXX International Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • Catabasis Pharmaceuticals Inc (CATB):企業の財務・戦略的SWOT分析
    Summary Catabasis Pharmaceuticals Inc (Catabasis Pharmaceuticals) is a clinical-stage biopharmaceutical company that discovers, develops and commercializes medicines for the treatment of multiple diseases. The company develops its product candidates using its proprietary safely metabolized and ratio …
  • Peco Energy Company:電力:M&Aディール及び事業提携情報
    Summary PECO Energy Company (PECO), a subsidiary of Exelon Corporation, is a public utility that purchases and sells electricity and gas, and provides electricity transmission and distribution, and gas distribution services. It supplies electricity and gas to residential, commercial, and industrial …
  • Cascadian Therapeutics Inc (CASC):製薬・医療:M&Aディール及び事業提携情報
    Summary Cascadian Therapeutics Inc (Cascadian), formerly Oncothyreon Inc is a clinical-stage biotechnology company that develops therapeutic products for the treatment of cancer. The company’s lead clinical-stage product candidate includes ONT-380, an orally active and selective small-molecule HER2 …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆